Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1997 Nov 25;9424:13323-8. doi: 10.1073/pnas.94.24.13323.
Show Gene links
Show Anatomy links
Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation.
Hering S
,
Aczél S
,
Kraus RL
,
Berjukow S
,
Striessnig J
,
Timin EN
.
???displayArticle.abstract???
The role of channel inactivation in the molecular mechanism of calcium (Ca2+) channel block by phenylalkylamines (PAA) was analyzed by designing mutant Ca2+ channels that carry the high affinity determinants of the PAA receptor site [Hockerman, G. H., Johnson, B. D., Scheuer, T., and Catterall, W. A. (1995) J. Biol. Chem. 270, 22119-22122] but inactivate at different rates. Use-dependent block by PAAs was studied after expressing the mutant Ca2+ channels in Xenopus oocytes. Substitution of single putative pore-orientated amino acids in segment IIIS6 by alanine (F-1499-A, F-1500-A, F-1510-A, I-1514-A, and F-1515-A) gradually slowed channel inactivation and simultaneously reduced inhibition of barium currents (I(Ba)) by (-)D600 upon depolarization by 100 ms steps at 0.1 Hz. This apparent reduction in drug sensitivity was only evident if test pulses were applied at a low frequency of 0.1 Hz and almost disappeared at the frequency of 1 Hz. (-)D600 slowed I(Ba) recovery after maintained membrane depolarization (1-3 sec) to a comparable extent in all channel constructs. A drug-induced delay in the onset of I(Ba) recovery from inactivation suggests that PAAs promote the transition to a deep inactivated channel conformation. These findings indicate that apparent PAA sensitivity of Ca2+ channels is not only defined by drug interaction with its receptor site but also crucially dependent on intrinsic gating properties of the channel molecule. A molecular model for PAA-Ca2+ channel interaction that accounts for the relationship between drug induced inactivation and channel block by PAA is proposed.
Armstrong,
Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons.
1971, Pubmed
Armstrong,
Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons.
1971,
Pubmed
Armstrong,
Inactivation of the sodium channel. II. Gating current experiments.
1977,
Pubmed
Berjukov,
Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels.
1996,
Pubmed
Boyett,
Ultra-slow voltage-dependent inactivation of the calcium current in guinea-pig and ferret ventricular myocytes.
1994,
Pubmed
Catterall,
Receptor sites for Ca2+ channel antagonists.
1992,
Pubmed
Chiu,
Inactivation of sodium channels: second order kinetics in myelinated nerve.
1977,
Pubmed
Courtney,
Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA.
1975,
Pubmed
Degtiar,
Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site.
1997,
Pubmed
,
Xenbase
Döring,
Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A.
1996,
Pubmed
,
Xenbase
Grabner,
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
1996,
Pubmed
Grabner,
Calcium channels from Cyprinus carpio skeletal muscle.
1991,
Pubmed
Hering,
Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.
1993,
Pubmed
Hering,
Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels.
1996,
Pubmed
,
Xenbase
Hering,
Mechanism of calcium channel block by D600 in single smooth muscle cells from rabbit ear artery.
1989,
Pubmed
Hescheler,
Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane?
1982,
Pubmed
Hockerman,
Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels.
1995,
Pubmed
Hondeghem,
Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.
1984,
Pubmed
Horton,
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.
1989,
Pubmed
Kass,
Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium.
1991,
Pubmed
Khodorov,
Effect of procaine and calcium ions on slow sodium inactivation in the frog Ranvier node membrane.
1974,
Pubmed
Klöckner,
Myocytes isolated from porcine coronary arteries: reduction of currents through L-type Ca-channels by verapamil-type Ca-antagonists.
1991,
Pubmed
Lacinová,
The block of the expressed L-type calcium channel is modulated by the beta 3 subunit.
1995,
Pubmed
Lee,
Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.
1983,
Pubmed
McDonald,
Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock.
1984,
Pubmed
Mikami,
Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel.
1989,
Pubmed
,
Xenbase
Mori,
Primary structure and functional expression from complementary DNA of a brain calcium channel.
1991,
Pubmed
,
Xenbase
Oyama,
D-600 blocks open Ca2+ channels more profoundly than closed ones.
1987,
Pubmed
Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed
Seydl,
The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side.
1993,
Pubmed
Starmer,
Phasic ion channel blockade. A kinetic model and parameter estimation procedure.
1985,
Pubmed
White,
Participation of intracellular sites in the action of Ca2+ channel blockers.
1986,
Pubmed
Zhang,
Molecular determinants of voltage-dependent inactivation in calcium channels.
1994,
Pubmed
,
Xenbase
